FALCONE, ALFREDO Statistiche
FALCONE, ALFREDO
DIPARTIMENTO DI RICERCA TRASLAZIONALE E DELLE NUOVE TECNOLOGIE IN MEDICINA E CHIRURGIA
5 FU + Irinotecan
2003-01-01 Falcone, Alfredo; Masi, G.; Cupini, S.; Cerri, E.; Allegrini, G.
5-fluorouracil administered as a 48-hour chronomodulated infusion in combination with leucovorin and cisplatin: a randomized phase II study in metastatic colorectal cancer
2001-01-01 Falcone, Alfredo; Allegrini, G; Masi, G; Lencioni, M; Pfanner, E; Brunetti, I; Danesi, Romano; Bocci, Guido; DEL TACCA, M; Conte, P.
5-fluorouracil administered as a 48-hours semi-intermittent infusion in combination with leucovorin, cisplatin and epirubicin
2004-01-01 Allegrini, G.; Falcone, Alfredo; DI MARSICO, R.; Lencioni, M.; Masi, G.; Galli, C.; Cupini, S.; Pfanner, E.; Marcucci, L.
5-fluorouracil enhances azidothymidine cytotoxicity. In vitro, in vivo and biochemical studies
1990-01-01 I., Brunetti; Falcone, Alfredo; Jw, Darnowski; P., Calabresi
5-Fluorouracil exposure in adjuvant chemotherapy regimens is significantly related to disease free survival in colorectal cancer patients
2006-01-01 DI PAOLO, Antonello; M., Lencioni; F., Amatori; S., DI DONATO; F., Federici; Bocci, Guido; Falcone, Alfredo; S., Ricci; M., DEL TACCA; Danesi, Romano
5-Fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer
2008-01-01 DI PAOLO, Antonello; Lencioni, M; Amatori, F; DI DONATO, S; Bocci, Guido; Orlandini, C; Lastella, M; Federici, F; Iannopollo, M; Falcone, Alfredo; Ricci, S; DEL TACCA, M; Danesi, Romano
A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer
2008-01-01 Fornaro, L.; Masi, G.; Bursi, S.; Loupakis, F.; Vasile, E.; Antonuzzo, A.; Chiara, S.; Pfanner, E.; DI PAOLO, Antonello; Bocci, Guido; DEL TACCA, M.; Falcone, Alfredo
A multicenter phase II study of sequential gemcitabine followed by docetaxel in elderly advanced non-small cell lung cancer (NSCLC) patients from the Polmone Toscano Group (POLTO)
2006-01-01 E., Vasile; C., Tibaldi; A., Antonuzzo; G., Tartarelli; D., Amoroso; R., DI MARSICO; A., Fabbri; F., Innocenti; A., Chioni; A., Nacci; S., Ricci; M., Andreuccetti; Falcone, Alfredo
A multicenter, randomized phase III study of second-line chemotherapy (CT) with or without bevacizumab (BV) in metastatic colorectal cancer (MCRC) patients who progressed to a first-line treatment containing bv: results from the bebyp trial by the Gruppo Oncologico Nord Ovest (GONO).
2012-01-01 Salvatore, L; Masi, G; Loupakis, F; Cremolini, Chiara; Schirripa, M; Fornaro, L; Antoniotti, C; Vivaldi, C; Granetto, C; Fea, E; Antonuzzo, L; Giommoni, E; Boni, C; Banzi, M; Chiara, S; Sonaglio, C; Allegrini, G; Marcucci, L; Valsuani, C; Greco, F; Safina, V; Boni, L; Falcone, Alfredo
A new model of early supportive care and symptoms management: The experience of Pisa medical oncology.
2013-01-01 Antonuzzo, A; Vasile, E; Lucchesi, M; Ginocchi, L; Galli, L; BRUNETTI I., M; Ricci, S; Falcone, Alfredo
A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients.
2008-01-01 Allegrini, G.; Falcone, Alfredo; Fioravanti, Anna; Barletta, M. T.; Orlandi, Paola; Loupakis, F.; Cerri, E.; Masi, G.; DI PAOLO, Antonello; Kerbel, R. S.; Danesi, Romano; Del Tacca, M.; Bocci, Guido
A phase I and pharmacokinetic study of irinotecan given as a 7-day continuous infusion in metastatic colorectal cancer patients pretreated with 5-fluorouracil or raltitrexed
2004-01-01 Masi, G; Falcone, Alfredo; DI PAOLO, Antonello; Allegrini, G; Danesi, Romano; Barbara, C; Cupini, S; DEL TACCA, Mario
A phase I-II study of oral doxifluridine plus radiotherapy in radiosensitive tumors of the pelvic region
1993-01-01 S., Spagnesi; F., Ducci; M., Laddaga; Falcone, Alfredo; Pf, Conte; A., Pandolfi; C., GALLO STAMPINO
A phase II pilot study of sequential chemo-immunotherapy with capecitabina+ interferon α2A (IFN) followed by interleukina-2 (IL-2) in patients with metastatic renal cell carcinoma (MRCC): on behalf of the Gruppo Oncologico Nord Ovest (G.O.N.O.)
2006-01-01 E., Fontana; A., Fontana; C., Galli; L., Galli; A., Antonuzzo; L., Landi; M., LO DICO; E., Mazzoni; M., Andreuccetti; E., Aitini; B., Vivorio; P., Morselli; C., Cianci; A., Chioni; I., Pastina; S., Ricci; Falcone, Alfredo
A phase II study of oral doxifluridine in elderly patients with advanced non small cell lung cancer
1996-01-01 E., Baldini; C., Tibaldi; E., Pfanner; S., Ricci; Falcone, Alfredo; A., Ceribelli; R., Sarcina; G., Comella; C., GALLO STAMPINO; Pf, Conte
A PHASE ii TRIAL OF FIXED-DOSE RATE GEMCITABINE PLUS CAPECITABINE IN METASTATIC/ADVANCED BILIARY TRACT CANCER PATIENTS.
2012-01-01 Santini, D; Virzì, V; Vasile, E; Vincenzi, B; Catalano, V; Graziano, F; Masi, G; Bronte, G; Russo, A; Falcone, Alfredo; Tonini, G.
A PILOT STUDY OF A DAY ONE AND EIGHT EVERY THREE WEEKS ADMINISTRATION OF DOCETAXEL IN METASTATIC CANCER PATIENTS
2007-01-01 Martella, F; GIANNESSI P., G; DI MARSICO, R; Coltelli, L; Safina, V; Giuntini, N; Falcone, Alfredo
A randomised phase II study of cetuximab plus gemcitabine/cisplatin combination in advanced pancreatic cancer (APC)
2007-01-01 S., Cascinu; R., Berardi; R., Labianca; S., Siena; Falcone, Alfredo; E., Aitini; S., Barni; F., DI COSTANZO; L., Frontini; G., Tonini; S., Rota; I., Floriani; A., ZANIBONI ON BEHALF OF GISCAD
A randomized clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL (Docetaxel in Second-Line Treatment of Advanced Lung Cancer)
2004-01-01 Falcone, Alfredo; C. GRIDELLI C., Gallo; M., DI MAIO; E., Barletta; A., Illiano; P., Maione; S., Salvagli; F. V., Piantedosi; G., Palazzolo; O., Caffo; A., Cerebelli; P., Mozzanti; L., Brancaccio; M. A., Captano; L., Isa; S., Barbera; F., PERRONE ON BEHALF OF THE DISTAL
A retrospective analysis of her-2 hyperexpression in gastric and gastroesophageal junction (gej).
2012-01-01 Lencioni, M; Vasile, E; Ginocchi, L; DI MASO, L; Caparello, C; Caponi, S; Baretti, M; Lucchesi, M; DA PRAT, V; Belluomini, L; Ricci, S; Falcone, Alfredo; Ugolini, C; Fontanini, Gabriella; Solito, B; Santi, S; Fabrini, M. G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 5 FU + Irinotecan | 1-gen-2003 | Falcone, Alfredo; Masi, G.; Cupini, S.; Cerri, E.; Allegrini, G. | |
| 5-fluorouracil administered as a 48-hour chronomodulated infusion in combination with leucovorin and cisplatin: a randomized phase II study in metastatic colorectal cancer | 1-gen-2001 | Falcone, Alfredo; Allegrini, G; Masi, G; Lencioni, M; Pfanner, E; Brunetti, I; Danesi, Romano; Bocci, Guido; DEL TACCA, M; Conte, P. | |
| 5-fluorouracil administered as a 48-hours semi-intermittent infusion in combination with leucovorin, cisplatin and epirubicin | 1-gen-2004 | Allegrini, G.; Falcone, Alfredo; DI MARSICO, R.; Lencioni, M.; Masi, G.; Galli, C.; Cupini, S.; Pfanner, E.; Marcucci, L. | |
| 5-fluorouracil enhances azidothymidine cytotoxicity. In vitro, in vivo and biochemical studies | 1-gen-1990 | I., Brunetti; Falcone, Alfredo; Jw, Darnowski; P., Calabresi | |
| 5-Fluorouracil exposure in adjuvant chemotherapy regimens is significantly related to disease free survival in colorectal cancer patients | 1-gen-2006 | DI PAOLO, Antonello; M., Lencioni; F., Amatori; S., DI DONATO; F., Federici; Bocci, Guido; Falcone, Alfredo; S., Ricci; M., DEL TACCA; Danesi, Romano | |
| 5-Fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer | 1-gen-2008 | DI PAOLO, Antonello; Lencioni, M; Amatori, F; DI DONATO, S; Bocci, Guido; Orlandini, C; Lastella, M; Federici, F; Iannopollo, M; Falcone, Alfredo; Ricci, S; DEL TACCA, M; Danesi, Romano | |
| A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer | 1-gen-2008 | Fornaro, L.; Masi, G.; Bursi, S.; Loupakis, F.; Vasile, E.; Antonuzzo, A.; Chiara, S.; Pfanner, E.; DI PAOLO, Antonello; Bocci, Guido; DEL TACCA, M.; Falcone, Alfredo | |
| A multicenter phase II study of sequential gemcitabine followed by docetaxel in elderly advanced non-small cell lung cancer (NSCLC) patients from the Polmone Toscano Group (POLTO) | 1-gen-2006 | E., Vasile; C., Tibaldi; A., Antonuzzo; G., Tartarelli; D., Amoroso; R., DI MARSICO; A., Fabbri; F., Innocenti; A., Chioni; A., Nacci; S., Ricci; M., Andreuccetti; Falcone, Alfredo | |
| A multicenter, randomized phase III study of second-line chemotherapy (CT) with or without bevacizumab (BV) in metastatic colorectal cancer (MCRC) patients who progressed to a first-line treatment containing bv: results from the bebyp trial by the Gruppo Oncologico Nord Ovest (GONO). | 1-gen-2012 | Salvatore, L; Masi, G; Loupakis, F; Cremolini, Chiara; Schirripa, M; Fornaro, L; Antoniotti, C; Vivaldi, C; Granetto, C; Fea, E; Antonuzzo, L; Giommoni, E; Boni, C; Banzi, M; Chiara, S; Sonaglio, C; Allegrini, G; Marcucci, L; Valsuani, C; Greco, F; Safina, V; Boni, L; Falcone, Alfredo | |
| A new model of early supportive care and symptoms management: The experience of Pisa medical oncology. | 1-gen-2013 | Antonuzzo, A; Vasile, E; Lucchesi, M; Ginocchi, L; Galli, L; BRUNETTI I., M; Ricci, S; Falcone, Alfredo | |
| A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients. | 1-gen-2008 | Allegrini, G.; Falcone, Alfredo; Fioravanti, Anna; Barletta, M. T.; Orlandi, Paola; Loupakis, F.; Cerri, E.; Masi, G.; DI PAOLO, Antonello; Kerbel, R. S.; Danesi, Romano; Del Tacca, M.; Bocci, Guido | |
| A phase I and pharmacokinetic study of irinotecan given as a 7-day continuous infusion in metastatic colorectal cancer patients pretreated with 5-fluorouracil or raltitrexed | 1-gen-2004 | Masi, G; Falcone, Alfredo; DI PAOLO, Antonello; Allegrini, G; Danesi, Romano; Barbara, C; Cupini, S; DEL TACCA, Mario | |
| A phase I-II study of oral doxifluridine plus radiotherapy in radiosensitive tumors of the pelvic region | 1-gen-1993 | S., Spagnesi; F., Ducci; M., Laddaga; Falcone, Alfredo; Pf, Conte; A., Pandolfi; C., GALLO STAMPINO | |
| A phase II pilot study of sequential chemo-immunotherapy with capecitabina+ interferon α2A (IFN) followed by interleukina-2 (IL-2) in patients with metastatic renal cell carcinoma (MRCC): on behalf of the Gruppo Oncologico Nord Ovest (G.O.N.O.) | 1-gen-2006 | E., Fontana; A., Fontana; C., Galli; L., Galli; A., Antonuzzo; L., Landi; M., LO DICO; E., Mazzoni; M., Andreuccetti; E., Aitini; B., Vivorio; P., Morselli; C., Cianci; A., Chioni; I., Pastina; S., Ricci; Falcone, Alfredo | |
| A phase II study of oral doxifluridine in elderly patients with advanced non small cell lung cancer | 1-gen-1996 | E., Baldini; C., Tibaldi; E., Pfanner; S., Ricci; Falcone, Alfredo; A., Ceribelli; R., Sarcina; G., Comella; C., GALLO STAMPINO; Pf, Conte | |
| A PHASE ii TRIAL OF FIXED-DOSE RATE GEMCITABINE PLUS CAPECITABINE IN METASTATIC/ADVANCED BILIARY TRACT CANCER PATIENTS. | 1-gen-2012 | Santini, D; Virzì, V; Vasile, E; Vincenzi, B; Catalano, V; Graziano, F; Masi, G; Bronte, G; Russo, A; Falcone, Alfredo; Tonini, G. | |
| A PILOT STUDY OF A DAY ONE AND EIGHT EVERY THREE WEEKS ADMINISTRATION OF DOCETAXEL IN METASTATIC CANCER PATIENTS | 1-gen-2007 | Martella, F; GIANNESSI P., G; DI MARSICO, R; Coltelli, L; Safina, V; Giuntini, N; Falcone, Alfredo | |
| A randomised phase II study of cetuximab plus gemcitabine/cisplatin combination in advanced pancreatic cancer (APC) | 1-gen-2007 | S., Cascinu; R., Berardi; R., Labianca; S., Siena; Falcone, Alfredo; E., Aitini; S., Barni; F., DI COSTANZO; L., Frontini; G., Tonini; S., Rota; I., Floriani; A., ZANIBONI ON BEHALF OF GISCAD | |
| A randomized clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL (Docetaxel in Second-Line Treatment of Advanced Lung Cancer) | 1-gen-2004 | Falcone, Alfredo; C. GRIDELLI C., Gallo; M., DI MAIO; E., Barletta; A., Illiano; P., Maione; S., Salvagli; F. V., Piantedosi; G., Palazzolo; O., Caffo; A., Cerebelli; P., Mozzanti; L., Brancaccio; M. A., Captano; L., Isa; S., Barbera; F., PERRONE ON BEHALF OF THE DISTAL | |
| A retrospective analysis of her-2 hyperexpression in gastric and gastroesophageal junction (gej). | 1-gen-2012 | Lencioni, M; Vasile, E; Ginocchi, L; DI MASO, L; Caparello, C; Caponi, S; Baretti, M; Lucchesi, M; DA PRAT, V; Belluomini, L; Ricci, S; Falcone, Alfredo; Ugolini, C; Fontanini, Gabriella; Solito, B; Santi, S; Fabrini, M. G. |